Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > IL-22 R alpha 1

IL-22 R alpha 1

Brief Information

Name:Interleukin-22 receptor
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
IL1-H5258 Human Human IL-22 R alpha 1 Protein, Fc Tag
IL1-H5258-structure
IL1-H5258-sds
ACRO Quality

Part of Bioactivity data

IL1-H5258-BLI
IL-22 R alpha 1 BLI

Loaded Human IL-22 R alpha 1 Protein, Fc Tag (Cat. No. IL1-H5258) on Protein A Biosensor, can bind Human IL-24 Protein, His Tag (Cat. No. IL4-H52H4) with an affinity constant of 1.71 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
IL1-H5258-ELISA
IL-22 R alpha 1 ELISA

Immobilized Human IL-22, His Tag (Cat. No. IL2-H524a) at 5 μg/mL (100 μL/well) can bind Human IL-22 R alpha 1, Fc Tag (Cat. No. IL1-H5258) with a linear range of 2-78 ng/mL (QC tested).

Protocol

Synonym Name

Interleukin-22 receptor subunit alpha-1,IL-22 receptor subunit alpha-1,IL-22R-alpha-1,IL-22RA1,Cytokine receptor class-II member 9,Cytokine receptor family 2 member 9,CRF2-9,ZcytoR11,IL22RA1,IL22R

Background

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Efmarodocokin alfa RO-7021610; UTTR-1147A; RG-7880 Phase 2 Clinical Genentech Inc Diabetic Foot; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Colitis, Ulcerative; Crohn Disease Details
Temtokibart ARGX-112; LEO-138559; LP-0145 Phase 2 Clinical Argenx Se, Leo Pharma Inc Dermatitis, Atopic Details
Eflepedocokin alfa F-652 Phase 2 Clinical Evive Biotech Ltd Hepatitis, Alcoholic; Pancreatitis; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Acute-On-Chronic Liver Failure Details
CK-0045 CK-0045 Phase 1 Clinical Cytoki Pharma ApS Details
ABBV-022 ABBV-022 Phase 1 Clinical Abbvie Inc Colitis, Ulcerative Details
Efmarodocokin alfa RO-7021610; UTTR-1147A; RG-7880 Phase 2 Clinical Genentech Inc Diabetic Foot; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Colitis, Ulcerative; Crohn Disease Details
Temtokibart ARGX-112; LEO-138559; LP-0145 Phase 2 Clinical Argenx Se, Leo Pharma Inc Dermatitis, Atopic Details
Eflepedocokin alfa F-652 Phase 2 Clinical Evive Biotech Ltd Hepatitis, Alcoholic; Pancreatitis; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Acute-On-Chronic Liver Failure Details
CK-0045 CK-0045 Phase 1 Clinical Cytoki Pharma ApS Details
ABBV-022 ABBV-022 Phase 1 Clinical Abbvie Inc Colitis, Ulcerative Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap